Minimally Invasive Spine Surgery Market

The global Minimally Invasive Spine Surgery Market is valued at USD 2.2 Billion in 2023 and is projected to reach a value of USD 3.98 Billion by 2032 at a CAGR (Compound Annual Growth Rate) of 6.8% between 2024 and 2032.

The Minimally Invasive Spine Surgery market is driven by advancements in surgical technology, and increasing patient preference for procedures with reduced pain, faster recovery, and lower complication risks. Enhanced diagnostic capabilities, rising healthcare expenditure, and supportive reimbursement policies further contribute to the market's expansion.

Key Highlights

• In 2023, by Application, Fusion Surgery segment dominated with the market share of 60.2%, owing to the success of fusion techniques in offering enduring relief and stability for patients. This efficacy has facilitated broad adoption and reinforced its leading role in the market
• By Product, Implants & instrumentation dominated the market in 2023 with significant market share due to the essential role these components play in the successful performance of minimally invasive spine surgeries
• In 2023, North America led the market, capturing 42.2% market share due to the region's advanced healthcare infrastructure, high adoption of cutting-edge minimally invasive spine surgery technologies, and a significant prevalence of spinal disorders
• Baby Boomer spine surgeries are performed on majorly Spine surgeries are increasingly being performed on the Baby Boomer generation (Aged 60 to 78 years)
• The oblique and lateral lumbar spine surgeries are anticipated to experience greater growth compared to their posterior and transforaminal lumbar counterparts, though positive growth is expected all segments

Product Overview

By Product, the market is segmented into Implants & Instrumentation and Biomaterials. In 2023, the Implants & Instrumentation segment dominated the market with the largest share. Implants & Instrumentation are crucial for stabilizing the spine and ensuring accurate, minimally invasive procedures including spinal implants such as cages, rods, screws, and advanced surgical equipment. The need for reliable and effective implants has increased due to the rising demand for difficult surgeries such as spinal fusions, which has strengthened the market. This category includes a broad range of instruments that are essential to minimally invasive spine surgeries and are vital to the accurate and flawless execution of these procedures.

The implants and instrumentation segment is anticipated to hold the lead in the growing Minimally Invasive Spine Surgery market as a result of the ongoing advancements in surgical instruments and the growing complexity of spinal operations, leading to the need for advanced solutions. Advances like patient-specific implants manufactured in 3D space and the incorporation of robotics in spine surgery have improved the accuracy and efficiency of MIS procedures, spurring their widespread adoption. For instance, according to studies, over 500,000 lumbar spine surgeries are performed annually in the United States due to the 80% of Americans who would at some point in their lives have low back pain. The rise in Implants & instrumentation leads to less-invasive tools which enable smaller incisions and short recovery times.

Biomaterial segment is expected to witness fastest growth between 2024-2032. Biomaterials are biocompatible substances essential in the creation of surgical devices and implants used in minimally invasive spine surgeries. The growth of this segment is anticipated to be driven by strategic initiatives from market players, such as product launches, partnerships, and collaborations. For instance, in March 2023, Invibio Biomaterial Solutions introduced the Peek-Optima Am filament, an implantable polyetheretherketone polymer designed for manufacturing 3D-printed medical devices, including spinal implants.

Regional Overview

North America Dominated Sales with a 42.2% share in 2023.North America's dominance can be attributed to the growing incidence of spinal disorders in the geriatric population, which has further increased demand for minimally invasive surgery (MIS) in North America and high adoption rates of modern medical technologies. For instance, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, marking a 47% increase.

The U.S. dominated the regional segment in terms of revenue on account of its established network of hospitals. In addition, highly competent surgeons who are increasingly opting for MIS procedures is proliferating the market growth. In 2023, the annual incidence of traumatic spinal cord injury (tSCI) in the United States was approximately 54 cases per one million people as per National Spinal Cord Injury Statistical Center. Innovations by market players are fueling the expansion of the Minimally Invasive Spine Surgery market. For instance, in August 2022, Nexus Spine introduced the PressON posterior lumbar fixation system in the U.S., which features a design that is about one-fourth the size of traditional systems, allowing for quicker implantation and enhanced biomechanical strength. Similarly, in March 2022, Accelus performed a surgery utilizing its Remi Robotic Navigation, LineSider Spinal System, and FlareHawk Expandable Spine Interbody Fusion Device technologies in a single procedure. These technological advancements are anticipated to drive increased demand for minimally invasive spine surgery products, further accelerating market growth in the region during the forecast period.

Europe Overview

In 2023, Medtronic held the leading share of the European Minimally Invasive Spine Surgery market, driven by strong performance across several segments, including MIS interbody devices, MIS pedicle screws, spinous process fixation, and facet fixation. However, the company was not active in the spine endoscope market.

DePuy Synthes has major share, excelling in the MIS interbody, MIS pedicle screw, and facet fixation segments, where it was the market leader. DePuy Synthes did not participate in the spinous process fixation, MIS SI joint fusion, or spine endoscope segments.

Other prominent competitors in Europe included Globus Medical/NuVasive, Stryker, SI-BONE, Richard Wolf, and ZimVie/Highridge Medical, alongside numerous smaller companies.

Top Trends

• Adoption of Robotic-Assisted Surgery: The integration of robotic systems with advanced imaging and navigation tools is enabling surgeons to perform intricate spinal surgeries with greater accuracy and efficiency.
• Advancements in Imaging and Navigation Technologies: The development of cutting-edge imaging and navigation systems is revolutionizing the MIS market. Technologies such as intraoperative CT, MRI, and augmented reality (AR) are providing surgeons with real-time, high-resolution views of the surgical site.
• Personalized and Patient-Specific Implants: Advances in 3D printing and custom implant design allow for the creation of implants tailored to the unique anatomy of individual patients.
• Increased Focus on Pain Management and Enhanced Recovery Protocols: Minimizing postoperative pain and enhancing recovery are key areas of focus in MIS. Enhanced recovery after surgery (ERAS) protocols, which include multimodal pain management, early mobilization, and patient education, are being increasingly adopted.

Premium Insights

‹›

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

• Real-Time Data Updates:
• Competitor Benchmarking
• Market Trends Heatmap
• Custom Research Queries
• Market Sentiment Analysis
• Demographic and Geographic Insights

Book Demo

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

Increase in incidences of spinal disorders is a primary driver for market growth

The incidence of spinal conditions such as herniated discs, spinal stenosis, and degenerative disc disease is on the rise in the geriatric population. These conditions often require surgical intervention, and minimally invasive techniques. MIS are increasingly preferred due to their advantages over traditional open surgeries. MIS procedures typically result in smaller incisions, less blood loss, reduced postoperative pain, and quicker recovery times. The use of MIS operations has also been accelerated by developments in imaging technologies, surgical instruments, and techniques, which have increased accessibility and safety.

High cost of surgical procedure is expected to hamper the market

The increased expenses can be difficult for individuals as well as healthcare providers because of the complicated equipment and technology needed for MIS operations. Moreover, adequate medical reimbursement systems that fully reimburse the cost of MIS operations are not present in many areas. Patients' access to these cutting-edge treatments may be limited if they are not able to cover the costs for them out of pocket due to inadequate insurance coverage or government assistance. The adoption of MIS technology may be slowed down by this financial barrier, especially in areas with weak healthcare systems and populations with lower income.

Increasing investments in R&D may open avenues for Minimally Invasive Spine Surgery market

The ongoing focus on R&D is expected to create opportunities in the market. The capabilities of MIS are being expanded by innovations including biologic materials for spinal fusion, advanced navigation systems, and robotic-assisted procedures. These advancements allow for the treatment of a greater variety of spinal diseases with even less invasiveness. Furthermore, the pace of innovation is being accelerated through partnerships between medical technology businesses, academic institutions, and healthcare providers. This is leading to the development and commercialization of innovative technologies at a faster rate.

Competitive Landscape

Key companies in the Minimally Invasive Spine Surgery market are consistently innovating and making strategic developments. Innovative equipment and technology are propelling the market ahead, due to companies like Medtronic, Wenzel Spine, and Nexus Spine. With the introduction of the Stable-C cervical interbody fusion implants with integrated anchoring blades by Nexus Spine, Wenzel Spine has increased the scope of its products with the S-LIF Procedure for Stand-alone Lumbar Interbody Fusion utilizing the VariLift-LX apparatus. With the recent CE Mark clearance of the Affera Mapping and Ablation System by Medtronic, these firms are positioned as pioneers in the rapidly changing field of spinal surgery solutions, highlighting the trend towards more accurate and successful treatment alternatives.

The key players in the global Minimally Invasive Spine Surgery market include - Medtronic plc, Braun Melsungen AG, MicroPort Scientific Corporation, Aesculap Implant Systems LLC, Alphatec Holdings Inc., RTI Surgical Holdings Inc., Orthofix Medical Inc., K2M Group Holdings Inc., SeaSpine Holdings Corporation, CoreLink LLC, NuVasive Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., DePuy Synthes (Johnson & Johnson) among others.

Recent Market Developments

Pioneering Endoscopic Spine Surgery: A Next-Generation Solution for Rapid Recovery

• In 2024, An innovative ultra-minimally invasive procedure known as endoscopic spine surgery (ESS) is now available in Chicago, performed by Dr. Kern Singh of Midwest Orthopaedics at RUSH for the patients requiring spine surgery. As a pioneer in this advanced technique, Dr. Singh is at the forefront of what is considered the 'next generation' of minimally invasive spine surgery

Medtronic Secures CE Mark Approval for Affera Mapping and Ablation System for Atrial Arrhythmias

• In 2023, Medtronic received CE Mark approval for its Affera Mapping and Ablation System. This advanced system is designed to address atrial arrhythmias, offering precise mapping and ablation capabilities to assist healthcare professionals in effectively treating cardiac rhythm disorders.

Wenzel Spine Introduces S-LIF Procedure for Lumbar Interbody Fusion Using VariLift-LX Device

• In August 2022, Wenzel Spine, Inc., a medical technology company specializing in minimally invasive surgical and diagnostic solutions for spinal disorders, introduced the S-LIF Procedure for Stand-alone Lumbar Interbody Fusion using the VariLift-LX device

Nexus Spine Launches Stable-C Cervical Implants with Integrated Anchoring Blades

• In July 2022, Nexus Spine, a developer of biomechanically advanced solutions for spinal pathologies, launched its Stable-C cervical interbody fusion implants, which feature integrated anchoring blades

The global Minimally Invasive Spine Surgery market can be categorized as Product, Application, Treatment, End Users and Region.